TY - JOUR
T1 - Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress
AU - Ward, Chris
AU - Curry, Nicola
AU - El-Ekiaby, Magdy
AU - Jurk, Kerstin
AU - Versteeg, Henri H.
AU - Keragala, Charithani
AU - Burstyn-Cohen, Tal
AU - Antoniak, Silvio
AU - Suzuki, Yuko
AU - Baker, Ross I.
AU - Christophe, Olivier
AU - Revel-Vilk, Shoshana
AU - Hart, Alice
AU - Deppermann, Carsten
AU - Tran, Huyen
AU - Pozzi, Nicola
AU - Kahr, Walter H.A.
AU - Grover, Steven P.
AU - Wenzel, Philip
AU - Brown, Ashley C.
AU - Oury, Cécile
AU - Shea, Susan M.
AU - Fredenburgh, James
AU - Passam, Freda H.
AU - Winearls, James
AU - Moore, Hunter B.
AU - Tole, Soumitra
AU - Merriman, Eileen
AU - Barnes, Geoffrey D.
AU - Liu, Z. Leonardo
AU - Sholzberg, Michelle
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/5
Y1 - 2024/5
N2 - Here, we present a series of illustrated capsules from the State of the Art (SOA) speakers at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. This year's Congress marks the first time that the International Society on Thrombosis and Haemostasis has held its flagship scientific meeting in Southeast Asia and is the first to be organized by an international Planning Committee. The Bangkok program will feature innovative science and clinical updates from around the world, reflecting the diversity and multidisciplinary growth of our field. In these illustrated SOA capsules, you will find an exploration of novel models of thrombosis and bleeding and biomaterial discoveries that can trigger or block coagulation. Thromboinflammation is now understood to drive many disease states, and the SOA speakers cover cellular and coagulation responses to COVID-19 and other infections. The theme of crosstalk between coagulation and inflammation expands with capsules on protein S signaling, complement, and fibrinolytic inhibitors. Novel agents for hemophilia and thrombosis prevention are introduced. Challenging clinical conditions are also covered, such as inherited platelet disorders and antiphospholipid antibody syndrome. The scientific program in Bangkok will also showcase the work of clinicians and scientists from all parts of the world and chronicle real-world challenges. For example, 2 SOA capsules address the diagnosis and management of von Willebrand disease in low-income settings. Take some time to browse through these short illustrated reviews; we're sure that you'll be entertained, educated, and inspired to further explore the world of thrombosis and hemostasis.
AB - Here, we present a series of illustrated capsules from the State of the Art (SOA) speakers at the 2024 International Society on Thrombosis and Haemostasis Congress in Bangkok, Thailand. This year's Congress marks the first time that the International Society on Thrombosis and Haemostasis has held its flagship scientific meeting in Southeast Asia and is the first to be organized by an international Planning Committee. The Bangkok program will feature innovative science and clinical updates from around the world, reflecting the diversity and multidisciplinary growth of our field. In these illustrated SOA capsules, you will find an exploration of novel models of thrombosis and bleeding and biomaterial discoveries that can trigger or block coagulation. Thromboinflammation is now understood to drive many disease states, and the SOA speakers cover cellular and coagulation responses to COVID-19 and other infections. The theme of crosstalk between coagulation and inflammation expands with capsules on protein S signaling, complement, and fibrinolytic inhibitors. Novel agents for hemophilia and thrombosis prevention are introduced. Challenging clinical conditions are also covered, such as inherited platelet disorders and antiphospholipid antibody syndrome. The scientific program in Bangkok will also showcase the work of clinicians and scientists from all parts of the world and chronicle real-world challenges. For example, 2 SOA capsules address the diagnosis and management of von Willebrand disease in low-income settings. Take some time to browse through these short illustrated reviews; we're sure that you'll be entertained, educated, and inspired to further explore the world of thrombosis and hemostasis.
UR - http://www.scopus.com/inward/record.url?scp=85194150527&partnerID=8YFLogxK
U2 - 10.1016/j.rpth.2024.102432
DO - 10.1016/j.rpth.2024.102432
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38854821
AN - SCOPUS:85194150527
SN - 2475-0379
VL - 8
JO - Research and Practice in Thrombosis and Haemostasis
JF - Research and Practice in Thrombosis and Haemostasis
IS - 4
M1 - 102432
ER -